About RxData
RxData is a company based in New York (United States) founded in 2014 was acquired by Edra in July 2022. It operates as a SaaS (Software-as-a-Service). RxData offers products and services including RxData Platform. RxData operates in a competitive market with competitors including MMIT Network, Posos, Lyfegen, One bio and Memed, among others.
- Headquarter New York, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RxData
RxData offers a comprehensive portfolio of products and services, including RxData Platform.
Market access intelligence is provided for pharmaceutical decisions.
People of RxData
Unlock access to complete
Unlock access to complete
Funding Insights of RxData
Investors in RxData
RxData has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Edra and Blueprint Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A community of healthcare entrepreneurs is supported by Blueprint Health.
|
Locked | Locked | Locked | |
|
Premium home furniture is manufactured and retailed across multiple categories.
|
Locked | Locked | Locked |
Investor details for RxData
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RxData
Investment portfolio details for RxData
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RxData
Detailed financials for RxData
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rxdata Comparisons
Peer comparison for RxData
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RxData
RxData operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MMIT Network, Posos, Lyfegen, One bio and Memed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers formulary data & analytics for market research, medication decision & formulary management
|
|
| Locked | Locked | Locked |
AI-based drug information and patient profiling tool for healthcare professionals
|
|
| Locked | Locked | Locked |
Provider of pricing model databases for drugs and medical devices
|
|
| Locked | Locked | Locked |
Online tools for partner management and opportunity screening.
|
|
| Locked | Locked | Locked |
Application with curated drug information used by physicians
|
|
| Locked | Locked | Locked |
Drug decision support engine is provided for healthcare professionals.
|
Detailed competitors of RxData
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rxdata
Complete news archive for RxData
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RxData
RxData was founded in 2014.
RxData is headquartered in New York, United States. It is registered at New York, New York, United States.
RxData is recognized for providing market access intelligence to the pharmaceutical industry. Comprehensive data on regulatory decisions, HTA publications, reimbursement decisions, and global list prices are curated and presented through the RxData platform. Coverage spans over 100 data sources, ensuring detailed insights across events, coverage, and pricing. Solutions are designed to reduce research time by up to 95, enabling faster go-to-market strategies. The platform supports analogue analysis, competitive edge through curated data, and real-time monitoring for better decision-making in major global markets.
RxData's top competitors include MMIT Network, Lyfegen and One bio.
RxData offers RxData Platform.
RxData has 2 investors. Key investors include Edra, and Blueprint Health.